Lung cancer gene test could personalize treatment
NCT ID NCT01487603
First seen May 15, 2026 · Last updated May 15, 2026
Summary
This study looks at whether tissue samples taken during a routine lung biopsy (called EBUS-TBNA) can be used to analyze gene changes in lung cancer. The goal is to see if these gene changes can help predict which treatments—like surgery, chemo, or radiation—will work best for each patient. About 400 adults with confirmed or suspected lung cancer will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
University Health Network
RECRUITINGToronto, Ontario, Canada
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.